Acute encephalopathy and cerebral vasospasm after multiagent chemotherapy including PEG-asparaginase and intrathecal cytarabine for the treatment of acute lymphoblastic leukemia

J Pediatr Hematol Oncol. 2007 Mar;29(3):183-6. doi: 10.1097/MPH.0b013e3180335043.

Abstract

A 7-year-old girl with an unusual reaction to induction chemotherapy for precursor B-cell acute lymphoblastic leukemia (ALL) is described. The patient developed acute encephalopathy evidenced by behavioral changes, aphasia, incontinence, visual hallucinations, and right-sided weakness with diffuse cerebral vasospasm on magnetic resonance angiography after the administration of intrathecal cytarabine. Vincristine, dexamethasone, and polyethylene glycol-asparaginase were also administered before the episode as part of induction therapy. Neurologic status returned to baseline within 10 days of the acute event, and magnetic resonance angiography findings returned to normal 4 months later.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Asparaginase / administration & dosage
  • Asparaginase / adverse effects*
  • Brain / pathology
  • Brain Diseases / chemically induced*
  • Brain Diseases / pathology
  • Burkitt Lymphoma / drug therapy*
  • Child
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects*
  • Female
  • Follow-Up Studies
  • Humans
  • Injections, Spinal
  • Magnetic Resonance Angiography / methods
  • Polyethylene Glycols / administration & dosage
  • Polyethylene Glycols / adverse effects*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Sensitivity and Specificity
  • Treatment Outcome
  • Vasospasm, Intracranial / chemically induced*
  • Vasospasm, Intracranial / pathology

Substances

  • Cytarabine
  • Polyethylene Glycols
  • pegaspargase
  • Asparaginase